Literature DB >> 25115595

Reinforcer magnitude and rate dependency: evaluation of resistance-to-change mechanisms.

Jonathan W Pinkston1, Brett C Ginsburg, Richard J Lamb.   

Abstract

Under many circumstances, reinforcer magnitude appears to modulate the rate-dependent effects of drugs such that when schedules arrange for relatively larger reinforcer magnitudes rate dependency is attenuated compared with behavior maintained by smaller magnitudes. The current literature on resistance to change suggests that increased reinforcer density strengthens operant behavior, and such strengthening effects appear to extend to the temporal control of behavior. As rate dependency may be understood as a loss of temporal control, the effects of reinforcer magnitude on rate dependency may be due to increased resistance to disruption of temporally controlled behavior. In the present experiments, pigeons earned different magnitudes of grain during signaled components of a multiple FI schedule. Three drugs, clonidine, haloperidol, and morphine, were examined. All three decreased overall rates of key pecking; however, only the effects of clonidine were attenuated as reinforcer magnitude increased. An analysis of within-interval performance found rate-dependent effects for clonidine and morphine; however, these effects were not modulated by reinforcer magnitude. In addition, we included prefeeding and extinction conditions, standard tests used to measure resistance to change. In general, rate-decreasing effects of prefeeding and extinction were attenuated by increasing reinforcer magnitudes. Rate-dependent analyses of prefeeding showed rate-dependency following those tests, but in no case were these effects modulated by reinforcer magnitude. The results suggest that a resistance-to-change interpretation of the effects of reinforcer magnitude on rate dependency is not viable.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25115595      PMCID: PMC4469476          DOI: 10.1097/FBP.0000000000000077

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  24 in total

1.  Effects of cocaine and morphine under mixed-ratio schedules of food delivery: support for a behavioral momentum analysis.

Authors:  A Poling; T Byrne; L Christian; M G Lesage
Journal:  Pharmacol Biochem Behav       Date:  2000-06       Impact factor: 3.533

Review 2.  Rate-dependent effects of drugs: a review of the literature.

Authors:  D J Sanger; D E Blackman
Journal:  Pharmacol Biochem Behav       Date:  1976-01       Impact factor: 3.533

3.  Clonidine improves attentional and memory components of delayed response performance in a model of early Parkinsonism.

Authors:  J S Schneider; J P Tinker; E Decamp
Journal:  Behav Brain Res       Date:  2010-03-27       Impact factor: 3.332

4.  Peter B. Dews and pharmacological studies on behavior.

Authors:  James E Barrett; Jack Bergman
Journal:  J Pharmacol Exp Ther       Date:  2008-06-10       Impact factor: 4.030

Review 5.  Determinants of the specificity of behavioral effects of drugs.

Authors:  R T Kelleher; W H Morse
Journal:  Ergeb Physiol       Date:  1968

6.  Rate dependency, behavioral mechanisms, and behavioral pharmacology.

Authors:  M N Branch
Journal:  J Exp Anal Behav       Date:  1984-11       Impact factor: 2.468

7.  Rate-dependent Effects of drugs. II. effects of some major tranquilizers on multiple fixed-ratio, fixed-interval schedule performance.

Authors:  J D Leander
Journal:  J Pharmacol Exp Ther       Date:  1975-05       Impact factor: 4.030

8.  Treatment with the noradrenergic alpha-2 agonist clonidine, but not diazepam, improves spatial working memory in normal young rhesus monkeys.

Authors:  J S Franowicz; A F Arnsten
Journal:  Neuropsychopharmacology       Date:  1999-11       Impact factor: 7.853

9.  Reinforcement magnitude modulation of rate-dependent effects of fluvoxamine and desipramine in the rat.

Authors:  Brett C Ginsburg; Richard J Lamb
Journal:  Behav Pharmacol       Date:  2008-12       Impact factor: 2.293

Review 10.  A review of the rationale and clinical utilization of α2-adrenoceptor agonists for the treatment of attention-deficit/hyperactivity and related disorders.

Authors:  Floyd Sallee; Daniel F Connor; Jeffrey H Newcorn
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-06       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.